+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Cancer Vaccine Pipeline Analysis

  • ID: 2720187
  • Drug Pipelines
  • Region: United States
  • 300 Pages
  • PNS Pharma
1 of 3
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost.

Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer. Merck's Gardasil, a Prophylactic cancer vaccine, along with GSK's Cervarix are some of the first vaccines to have gained attention globally with their blockbuster status.

The market for cancer vaccine is in its growth stage in the US and has great opportunities for entry. Constituting almost 50% of the global pie, the US cancer vaccine market was estimated to be worth USD 14 Billion in 2012. With close to 1.5 million Americans being diagnosed with cancer every year, this market is expected to o reach USD 20 billion by 2020.

- US Cancer Vaccine Pipeline Analysis - gives comprehensive insight on the various vaccines being developed for the treatment of various cancers. Research report covers all vaccines being developed in various development phases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the US cancer vaccine market based upon development process.

Following parameters for each orphan designated drug profile in development phase are covered in - US Cancer Vaccine Pipeline Analysis - research report:

- Drug Profile Overview
- Alternate Names for Drug
- Active Indication
- Phase of Development
- Mechanism of Action
- Brand Name
- Patent Information
- Orphan Designation by Indication, Country & Organisation
- Country for Clinical Trial
- Owner / Originator/ Licensee/Collaborator
- Administrative Route
- Drug Class
- ATC Codes

US Cancer Vaccine Pipeline by Clinical Phase:

- Research: 2
- Preclinical: 38
- Clinical: 2
- Phase-0: 1
- Phase-I: 35
- Phase-I/II: 19
- Phase-II: 32
- Phase-II/III: 2
- Phase-III: 17
- Marketed: 5
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. US Cancer Vaccine Market Overview

2. US Cancer Vaccine Market Regulations
2.1 Considerations for Both Early and Late Phase Clinical Trials
2.2 Considerations for Early Phase Clinical Trials
2.3 Considerations For Late Phase Clinical Trials

3. Cancer Vaccine Development Clinical Phase: Research
3.1 Overview
3.2 Cancer Vaccine Profile in Clinical Phase

4. Cancer Vaccine Development Clinical Phase: Preclinical
4.1 Overview
4.2 Cancer Vaccine Profile in Clinical Phase

5. Cancer Vaccine Development Clinical Phase: Clinical
5.1 Overview
5.2 Cancer Vaccine Profile in Clinical Phase

6. Cancer Vaccine Development Clinical Phase: Phase-0
6.1 Overview
6.2 Cancer Vaccine Profile in Clinical Phase

7. Cancer Vaccine Development Clinical Phase: Phase-I
7.1 Overview
7.2 Cancer Vaccine Profile in Clinical Phase

8. Cancer Vaccine Development Clinical Phase: Phase-I/II
8.1 Overview
8.2 Cancer Vaccine Profile in Clinical Phase

9. Cancer Vaccine Development Clinical Phase: Phase-II
9.1 Overview
9.2 Cancer Vaccine Profile in Clinical Phase

10. Cancer Vaccine Development Clinical Phase: Phase-II/III
10.1 Overview
10.2 Cancer Vaccine Profile in Clinical Phase

11. Cancer Vaccine Development Clinical Phase: Phase-III
11.1 Overview
11.2 Cancer Vaccine Profile in Clinical Phase

12. Marketed
12.1 Overview
12.2 Marketed Cancer Vaccine Profile

List of Tables:

- Alternate Names
- Originator & Owner
- Collaborator
- Technology Provider
- Licensee
- Highest Development Phase
- Indications
- Class
- Mechanism of Action
- ATC code
- Designated Brand Name & Orphan Designation
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/2720187
Adroll
adroll